Jun 4, 2020
The Silent Curve: Safety and Prioritization of ...
COVID-19 has not stopped cancer, but it has made it more difficult to detect cancer early.
Jun 1, 2020
Best Practices for Virtual Genetics & High-Risk ...
Cancer is now responsible for almost 1 in 6 deaths globally. More than 14 million people develop cancer every year, and this figure was projected to rise to over 21 million by 2030… before COVID-19 interrupted measures aiming to reduce cancer’s impact.
May 15, 2020
A Real-Life Example of a Telehealth ...
Fewer Americans have been getting cancer screenings like colonoscopies, mammograms and Pap smears since COVID-19 forced many clinics to put restrictions in place.
May 6, 2020
Addressing Concerns About Long-Term Impact of ...
Cancer programs across the country are all dealing with the effects of COVID-19 and trying to treat patients while keeping them safe. Advisory Board surveyed 55 programs to see how the pandemic has changed their operations.
Apr 1, 2020
Why Your Genetics and High Risk Programs are ...
Three months ago, health systems were embracing precision health strategies, and capturing the full clinical and financial value of using genetics in routine care. That’s before COVID-19 forced every US health group to close their doors to most patients. ...
Apr 1, 2020
How to Rapidly Deploy a Telehealth High Risk ...
COVID-19 has quickly altered society. It has changed workflows and processes and forced hospitals to discourage patients from coming in — to keep them safe and healthy.
Mar 25, 2020
COVID-19 Action Plan: Deliver Telehealth Services ...
We've been amazed to see teams across the country pulling together to take their cancer genetics programs virtual during these challenging times. To show our support, we commit to:
Mar 3, 2020
Generating Revenue from Your High Risk Program
Last month, we shared a story about how one of our clients (CHRISTUS Ochsner Lake Area Hospital’s Wellness, Screening, and Genetics Center) is using CancerIQ within their high-risk program.
Feb 27, 2020
HIMSS Session Not to Miss: Using FHIR to Fight ...
Hereditary cancer accounts for up to 10% of new cancer diagnoses. Although widespread adoption of affordable genetic testing is possible and highly valued, health systems struggle to identify candidates for genetic testing and manage those deemed to be ...
Jan 31, 2020
How to Calculate the ROI of Your Cancer Genetics ...
We speak with clients all of the time who are facing challenges justifying the investment in personnel and software support required to start, run, or grow their cancer genetic counseling and high risk programs.
